Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington’s disease
The authors show that Galectin-3 is up–regulated in brain tissues from patients and a mouse model of Huntington’s disease (HD) and correlates with disease severity. Galectin-3 accumulates at damaged lysosomes in HD microglia, prevents the clearance of damaged lysosomes, and promotes inflammation....
Enregistré dans:
Auteurs principaux: | Jian Jing Siew, Hui-Mei Chen, Huan-Yuan Chen, Hung-Lin Chen, Chiung-Mei Chen, Bing-Wen Soong, Yih-Ru Wu, Ching-Pang Chang, Yi-Chen Chan, Chun-Hung Lin, Fu-Tong Liu, Yijuang Chern |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a6e1aa100a154ae9b970e162e6e98c2c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Alterations of Plasma Galectin-3 and C3 Levels in Patients with Parkinson’s Disease
par: Hsiu-Chuan Wu, et autres
Publié: (2021) -
A system-wide mislocalization of RNA-binding proteins in motor neurons is a new feature of ALS
par: Yu-Ju Liu, et autres
Publié: (2021) -
Galectin-3 Inhibits Galectin-8/Parkin-Mediated Ubiquitination of Group A Streptococcus
par: Yi-Lin Cheng, et autres
Publié: (2017) -
Liquid-liquid phase separation and extracellular multivalent interactions in the tale of galectin-3
par: Yi-Ping Chiu, et autres
Publié: (2020) -
FBXO7 Y52C polymorphism as a potential protective factor in Parkinson's disease.
par: Chiung-Mei Chen, et autres
Publié: (2014)